Dr Mourad Wahba is leading a phase three clinical trial in Newcastle to test the efficacy of synthetic psilocybin for patients with treatment-resistant depression. By exploring new therapeutic options for those who have not responded to traditional methods, the research aims to provide a potential path forward for managing severe mood disorders.